Figure 2From: Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial Determining the long-term major adverse neurological event-free rate. Kaplan–Meier survival plot. Five-year cumulative (log-rank test) freedom from major adverse neurological event (MANE) was significantly higher in group 2 than in group 1 patients, P = 0.031.Back to article page